Uploaded August 2025 | Updated September 2026, 3 weeks ago

---

🔥 This week in GLP-1 news: Serena Williams may have grabbed headlines, but there were other GLP-1 news items. From a massive cancer study showing protective benefits, to new oral GLP-1 pills, Ozempic’s price cut to $499, a UK policy shift, U.S. cost debates, a new challenger drug from China, and Viking’s stock crash—this is everything you need to know in under 90 seconds.

💊 Topics Covered:
• GLP-1 cancer protection study
• Oral GLP-1 pills coming soon
• UK NHS diabetes policy shift
• U.S. cost-effectiveness debate
• Ecnoglutide: the new competitor
• Ozempic price drop to $499
• Viking’s GLP-1 trial stock tumble

👉 Don’t forget to like, comment, and subscribe for weekly GLP-1 updates!

#Ozempic #GLP1 #WeightLoss #Diabetes #HealthNews #mounjaro #zepbound #wegovy #cancer #cancerprevention